Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Area of Science:

• Oncology
• Immunology
• Cancer Stem Cell Biology

Background:

• Tumor recurrence and drug resistance significantly impact cancer patient prognosis.
• Cancer stem cells (CSCs) possess infinite proliferation potential and resist traditional therapies (chemo- and radiotherapy).
• CSCs are implicated in tumor recurrence and drug resistance, making them critical therapeutic targets.

Purpose of the Study:

• To review the interplay between cancer stem cells (CSCs) and emerging immunotherapies.
• To explore the potential of targeting CSCs in cancer immunotherapy for improved treatment outcomes.
• To provide insights into future therapeutic applications of CSC-targeted immunotherapies.

Main Methods:

• Literature review summarizing current research on CSCs and immunotherapy.
• Analysis of the role of CSCs in tumor recurrence and drug resistance.
• Examination of various immunotherapeutic approaches targeting CSCs.

Main Results:

• CSCs are central to tumor recurrence and drug resistance.
• CSCs express unique tumor-associated antigens, making them targets for immunotherapy.
• Immunotherapies (vaccines, checkpoint blockade, cell therapies) are more effective when targeting CSCs.

Conclusions:

• Targeting cancer stem cells (CSCs) with immunotherapy is a promising strategy to overcome tumor recurrence and drug resistance.
• Emerging immunotherapies selectively targeting CSCs may enhance current cancer treatment regimens.
• Future therapeutic combinations involving CSC-targeted immunotherapies hold significant potential for cancer treatment.